Related Experiment Video
Updated: Feb 2, 2026
06:19
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
1.5K
DIAGNOSTICS AND TREATMENT OF PERFORATED PYLORODUODENUM ULCERS IN WOMEN
Vestnik Khirurgii Imeni I. I. Grekova
|November 15, 2018
Summary
This study analyzed 75 women with perforated ulcers, finding laparoscopic surgery effective for wound closure and abdominal sanitation. Long-term outcomes were predominantly good or satisfactory, indicating successful treatment strategies for this patient group.
Area of Science:
- Gastroenterology
- Surgical Oncology
- Minimally Invasive Surgery
Background:
- Perforated ulcers pose significant surgical challenges, particularly in middle-aged and elderly female populations.
- Treatment strategies for perforated ulcers require careful consideration of surgical approach and patient outcomes.
Purpose of the Study:
- To evaluate the treatment outcomes of 75 women diagnosed with perforated ulcers.
- To compare the efficacy of different surgical methods, including laparoscopic and open approaches.
Main Methods:
- Analysis of treatment results for 75 female patients with perforated ulcers.
- Surgical interventions included laparoscopic wound closure and abdominal sanitation, midline laparotomy, mini-access procedures, and radical operations.
Main Results:
- Laparoscopic procedures were employed in 30.7% of cases, midline laparotomy in 29.3%, and mini-access techniques in 10.7%.
- Radical operations were performed in 16% of patients, with early postoperative complications occurring in 8.1% and a lethality rate of 4.0%.
- Long-term follow-up revealed good results in 55.5%, satisfactory in 30.1%, and unsatisfactory in 14.2% of cases.
Conclusions:
- Laparoscopic and minimally invasive approaches demonstrate favorable outcomes in the surgical management of perforated ulcers in women.
- While complications and lethality rates are present, long-term results suggest the effectiveness of current surgical strategies, with a majority experiencing good to satisfactory outcomes.
Related Concept Videos
01:29Drugs for Treatment of Ulcerative Colitis in IBD
519
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
519
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
596
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
596
01:22Esophageal Perforation-I: Introduction
600
Esophageal perforation is a severe medical condition characterized by a breach in the integrity of the esophageal wall. This breach can occur due to various factors such as trauma, medical procedures, or underlying diseases. When the esophageal wall is compromised, it allows food, fluids, and digestive juices into the chest cavity or adjacent structures, leading to potential complications and health risks.
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
600
01:28Peptic Ulcer Disease II: Pathophysiology
2.1K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.1K
01:28Esophageal Perforation-II: Clinical Manifestations and Management
727
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Clinical Manifestations:
727
01:30Peptic Ulcer Disease I: Introduction
835
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
835